We are bringing together two powerful teams of industry innovators and clinical experts. We now have a team of more than 100 specialists — medical geneticists, genetic counselors, primary care physicians, pharmacists and other specialists. In depth and scale, we offer the medical care of the future — today. We are your genomic specialists for life.

We are growing companies, and that won’t change — it will just accelerate. Our combined forces and resources will enable us to expand our teams, speed up technology development, foster innovation, and serve the needs of more patients and providers.

Our Series C was led by Casdin Capital, with participation from leading life sciences investors such as Perceptive Advisors, Amgen Ventures and GV (formerly Google Ventures). The support of these visionary investors is an acknowledgement that together, Genome Medical and GeneMatters will lead the way in rapidly opening up the genomics revolution through genetic health services and genomic care.